Drug Topics April 19, 2024
Brian Nowosielski

Representatives from the US Government Accountability Office (GAO) interviewed regulators from 5 states on pharmacy benefit manager laws.

The US Government Accountability Office (GAO) addressed the measures that states have taken to regulate pharmacy benefit managers (PBMs). Focusing on 5 states—Arkansas, California, Louisiana, Maine, and New York—the GAO found rules requiring drug-pricing transparency, pharmacy access, and licensure, among other things.

What’s the Issue?

PBMs are the “middlemen” between insurance plans, drug manufacturers, and patients. It is their job to administer prescription drug benefits and help control costs.1 However, they’ve come under recent fire for their ability to maliciously operate in the shadows to the detriment of patients and community pharmacies, which prompted the GAO’s report.

  • All 5 states enacted...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: GAO, Govt Agencies, Pharma, Pharma / Biotech, States, Survey / Study, Trends
Makary’s FDA Has Options In Industry Fight Over Weight Loss Drugs
Faster Cancer Drug Approvals Tied to Clinical Benefits
Skepticism Hangs Over Cancer Drugs Stuck With Accelerated Approval for Years
The Future of PBMs in 2025: AI, Regulations, and Transparency Initiatives
Q&A: Pharmacy Closures, PBM Reform, and How Pharmacists Can Effectively Advocate

Share This Article